Globus Medical GMED Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's gain/loss on asset sales?
- Globus Medical (GMED) reported gain/loss on asset sales of -$2.45M in Q1 2026.
- How has Globus Medical's gain/loss on asset sales changed year-over-year?
- Globus Medical's gain/loss on asset sales increased by 6.3% year-over-year, from -$2.61M to -$2.45M.
- What is the long-term trend for Globus Medical's gain/loss on asset sales?
- Over 4 years (2021 to 2025), Globus Medical's gain/loss on asset sales has grown at a 127.9% compound annual growth rate (CAGR), from -$464K to -$12.53M.
- What does gain/loss on asset sales mean?
- The accounting gain or loss recorded when selling long-term assets.
- How do you interpret gain/loss on asset sales?
- A large gain may indicate efficient asset management or divestiture of non-core assets, while a loss may suggest asset impairment or obsolescence.
- How does gain/loss on asset sales compare across companies?
- Standard across all capital-intensive industries; peers typically report this as a reconciliation adjustment.